Boston Therapeutics Inc

(BTHE)

By |

Profile

Boston Therapeutics Inc is a United States-based pre-clinical and clinical-stage pharmaceutical company. It focuses on the development, outsourced contract manufacture, and commercialization of carbohydrate-based therapeutic drugs and dietary supplements designed to address blood sugar management and inflammatory diseases. The lead pharmaceutical drug candidates include BTI-320 which is a non-systemic, carbohydrate-based compound designed to reduce post-meal elevation of blood glucose levels in diabetic patients, pre-diabetic patients; IPOXYN, a carbohydrate-based, an injectable drug intended to prevent necrosis and to treat hypoxic conditions; and BTI-410. It has developed Sugardown, which is a non-systemic, carbohydrate-based dietary supplement to support healthy blood glucose levels.

Contact Information

Website: www.bostonti.com
Main Phone: +1 603 935-9799
Address: 354 Merrimack Street No. 4
Address 2: Suite 300
State: MA
City / Town: Lawrence
Country: US
Postal Code: 01843

Issuer Information

Exchange: OTO
CEO: Chi-heng Cheng
Employees: 1
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

Profile

Boston Therapeutics Inc is a United States-based pre-clinical and clinical-stage pharmaceutical company. It focuses on the development, outsourced contract manufacture, and commercialization of carbohydrate-based therapeutic drugs and dietary supplements designed to address blood sugar management and inflammatory diseases. The lead pharmaceutical drug candidates include BTI-320 which is a non-systemic, carbohydrate-based compound designed to reduce post-meal elevation of blood glucose levels in diabetic patients, pre-diabetic patients; IPOXYN, a carbohydrate-based, an injectable drug intended to prevent necrosis and to treat hypoxic conditions; and BTI-410. It has developed Sugardown, which is a non-systemic, carbohydrate-based dietary supplement to support healthy blood glucose levels.

Contact Information

Website: www.bostonti.com
Main Phone: +1 603 935-9799
Address: 354 Merrimack Street No. 4
Address 2: Suite 300
State: MA
City / Town: Lawrence
Country: US
Postal Code: 01843

Issuer Information

Exchange: OTO
CEO: Chi-heng Cheng
Employees: 1
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

$ 0.0082 $ 0. (0.00%)
Last Price 0.0082 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open N/A High N/A Low N/A Prev Close 0.0082
Last Trade Volume 0 52 Wk Hi 0.03 52 Wk Low 0.01
Market Cap 911,277 Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 111,131,373.00 EPS (TTM) -0.04 PE Ratio N/A Exchange OTCPK
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 0
Number of Buys 0 0
Number of Sells 0 0
Net Activity 0 0
Last 10 Buys Shares
David Platt 1,000
Dale H. Conaway 1,000
David Platt 1,000
Anthony D. Squeglia 1,000
Alan M. Hoberman 1,000
David Platt 1,000
David Platt 1,000
David Platt 1,000
David Platt 1,000
David Platt 1,000
Last 10 Sell Shares
David Platt 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 1.12 1.12 1.12 1.12
Low Target Price Estimate 1.12 1.12 1.12 1.12
Mean Target Price Estimate 1.12 1.12 1.12 1.12
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 05/21/14 05/21/14 05/21/14 05/21/14
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 1
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 0 0 0 2